Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma.

Muller S, Victoria Lai W, Adusumilli PS, Desmeules P, Frosina D, Jungbluth A, Ni A, Eguchi T, Travis WD, Ladanyi M, Zauderer MG, Sauter JL.

Mod Pathol. 2019 Sep 19. doi: 10.1038/s41379-019-0364-z. [Epub ahead of print]

PMID:
31537897
2.

Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool in diagnosing secretory carcinoma of salivary gland and detecting ETV6-NTRK3 fusion.

Xu B, Haroon Al Rasheed MR, Antonescu CR, Alex D, Frosina D, Ghossein R, Jungbluth AA, Katabi N.

Histopathology. 2019 Aug 25. doi: 10.1111/his.13981. [Epub ahead of print]

PMID:
31448442
3.

CytoLyt fixation significantly inhibits MIB1 immunoreactivity whereas alternative Ki-67 clone 30-9 is not susceptible to the inhibition: Critical diagnostic implications.

Buonocore DJ, Konno F, Jungbluth AA, Frosina D, Fayad M, Edelweiss M, Lin O, Rekhtman N.

Cancer Cytopathol. 2019 Oct;127(10):643-649. doi: 10.1002/cncy.22170. Epub 2019 Aug 9.

PMID:
31398281
4.

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.

Solomon JP, Linkov I, Rosado A, Mullaney K, Rosen EY, Frosina D, Jungbluth AA, Zehir A, Benayed R, Drilon A, Hyman DM, Ladanyi M, Sireci AN, Hechtman JF.

Mod Pathol. 2019 Aug 2. doi: 10.1038/s41379-019-0324-7. [Epub ahead of print]

PMID:
31375766
5.

The immune microenvironment and expression of PD-L1, PD-1, PRAME and MHC I in salivary duct carcinoma.

Xu B, Jungbluth AA, Frosina D, Alzumaili B, Aleynick N, Slodkowska E, Higgins K, Ho A, Morris L, Ghossein R, Katabi N.

Histopathology. 2019 Jun 25. doi: 10.1111/his.13944. [Epub ahead of print]

PMID:
31237963
6.

Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations.

Suehara Y, Alex D, Bowman A, Middha S, Zehir A, Chakravarty D, Wang L, Jour G, Nafa K, Hayashi T, Jungbluth AA, Frosina D, Slotkin E, Shukla N, Meyers P, Healey JH, Hameed M, Ladanyi M.

Clin Cancer Res. 2019 Jun 7. doi: 10.1158/1078-0432.CCR-18-4032. [Epub ahead of print]

PMID:
31175097
7.

Performance of DAXX Immunohistochemistry as a Screen for DAXX Mutations in Pancreatic Neuroendocrine Tumors.

Hechtman JF, Klimstra DS, Nanjangud G, Frosina D, Shia J, Jungbluth AA.

Pancreas. 2019 Mar;48(3):396-399. doi: 10.1097/MPA.0000000000001256.

PMID:
30747827
8.

Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors.

Arias-Stella JA 3rd, Benayed R, Oliva E, Young RH, Hoang LN, Lee CH, Jungbluth AA, Frosina D, Soslow RA, Antonescu CR, Ladanyi M, Chiang S.

Am J Surg Pathol. 2019 Mar;43(3):382-388. doi: 10.1097/PAS.0000000000001196.

PMID:
30489320
9.

The role of a monoclonal antibody 11C8B1 as a diagnostic marker of IDH2-mutated sinonasal undifferentiated carcinoma.

Dogan S, Frosina D, Fayad M, de Oliveira TB, Alemar B, Rosenblum M, Tang LH, Hameed M, Xu B, Ghossein RA, Chute DJ, Weigelt B, Jungbluth AA.

Mod Pathol. 2019 Feb;32(2):205-215. doi: 10.1038/s41379-018-0126-3. Epub 2018 Sep 11.

PMID:
30206411
10.

Histone H3K36M mutation and trimethylation patterns in chondroblastoma.

Lu C, Ramirez D, Hwang S, Jungbluth A, Frosina D, Ntiamoah P, Healey J, Zhu G, Chen W, Klein M, Hameed M.

Histopathology. 2019 Jan;74(2):291-299. doi: 10.1111/his.13725. Epub 2018 Nov 4.

PMID:
30098026
11.

T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders.

Pulitzer M, Geller S, Kumar E, Frosina D, Moskowitz A, Horwitz S, Myskowski P, Kheterpal M, Chan A, Dogan A, Jungbluth A.

Histopathology. 2018 Oct;73(4):653-662. doi: 10.1111/his.13671. Epub 2018 Jul 27.

12.

NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.

Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR.

Am J Surg Pathol. 2018 Jun;42(6):791-798. doi: 10.1097/PAS.0000000000001055.

13.

Immunohistochemical Detection of γ/δ T Lymphocytes in Formalin-fixed Paraffin-embedded Tissues.

Jungbluth AA, Frosina D, Fayad M, Pulitzer MP, Dogan A, Busam KJ, Imai N, Gnjatic S.

Appl Immunohistochem Mol Morphol. 2019 Sep;27(8):581-583. doi: 10.1097/PAI.0000000000000650.

PMID:
29517505
14.

ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.

Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA 3rd, Oliva E, Young RH, Hensley ML, Leitao MM Jr, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S.

Mod Pathol. 2018 Apr;31(4):674-684. doi: 10.1038/modpathol.2017.162. Epub 2017 Dec 1.

15.

Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.

Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA.

Am J Surg Pathol. 2017 Nov;41(11):1547-1551. doi: 10.1097/PAS.0000000000000911.

16.

[Expression of cancer testis (CT) antigens in pediatric and adolescent melanomas].

Behrendt N, Schultewolter T, Busam K, Frosina D, Spagnoli G, Jungbluth A.

Pathologe. 2017 Jul;38(4):303-311. doi: 10.1007/s00292-017-0311-z. Review. German.

PMID:
28631119
17.

BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.

Chiang S, Lee CH, Stewart CJR, Oliva E, Hoang LN, Ali RH, Hensley ML, Arias-Stella JA 3rd, Frosina D, Jungbluth AA, Benayed R, Ladanyi M, Hameed M, Wang L, Kao YC, Antonescu CR, Soslow RA.

Mod Pathol. 2017 Sep;30(9):1251-1261. doi: 10.1038/modpathol.2017.42. Epub 2017 Jun 16.

18.

A Novel Technique for the Generation of Multitissue Blocks Using a Carrier.

Frosina D, Jungbluth AA.

Appl Immunohistochem Mol Morphol. 2016 Oct;24(9):668-672.

19.

Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2.

Avogadri F, Gnjatic S, Tassello J, Frosina D, Hanson N, Laudenbach M, Ritter E, Merghoub T, Busam KJ, Jungbluth AA.

Am J Dermatopathol. 2016 Mar;38(3):201-7. doi: 10.1097/DAD.0000000000000362.

20.

Expression of cancer testis antigens CT10 (MAGE-C2) and GAGE in gastrointestinal stromal tumors.

Ghadban T, Perez DR, Vashist YK, Bockhorn M, Koenig AM, El Gammal AT, Izbicki JR, Metzger U, Hauswirth F, Frosina D, Jungbluth AA.

Eur J Surg Oncol. 2014 Oct;40(10):1307-12. doi: 10.1016/j.ejso.2014.03.011. Epub 2014 Mar 27.

PMID:
24713551
21.

Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein.

Reis BS, Jungbluth AA, Frosina D, Holz M, Ritter E, Nakayama E, Ishida T, Obata Y, Carver B, Scher H, Scardino PT, Slovin S, Subudhi SK, Reuter VE, Savage C, Allison JP, Melamed J, Jäger E, Ritter G, Old LJ, Gnjatic S.

Clin Cancer Res. 2013 Nov 15;19(22):6112-25. doi: 10.1158/1078-0432.CCR-12-3580. Epub 2013 Sep 30.

22.

Cancer-testis antigen expression and immunogenicity in AL amyloidosis.

Rosenzweig MA, Landau H, Seldin D, O'Hara C, Girnius S, Hanson N, Frosina D, Sedrak C, Arcila M, Comenzo RL, Giralt S, Gnjatic S, Jungbluth AA, Koehne G.

Blood Cancer J. 2012 Sep 14;2:e90. doi: 10.1038/bcj.2012.32.

23.

Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients.

Inaoka RJ, Jungbluth AA, Gnjatic S, Ritter E, Hanson NC, Frosina D, Tassello J, Etto LY, Bortoluzzo AB, Alves AC, Colleoni GW.

Cancer Immunol Immunother. 2012 Dec;61(12):2207-14. doi: 10.1007/s00262-012-1285-6. Epub 2012 May 26.

PMID:
22638551
24.

An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients.

Inaoka RJ, Jungbluth AA, Baiocchi OC, Assis MC, Hanson NC, Frosina D, Tassello J, Bortoluzzo AB, Alves AC, Colleoni GW.

BMC Cancer. 2011 Sep 28;11(1):416.

25.

Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium.

Trimble CL, Clark RA, Thoburn C, Hanson NC, Tassello J, Frosina D, Kos F, Teague J, Jiang Y, Barat NC, Jungbluth AA.

J Immunol. 2010 Dec 1;185(11):7107-14. doi: 10.4049/jimmunol.1002756. Epub 2010 Oct 29.

26.

Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas.

Busam KJ, Jungbluth AA, Rekthman N, Coit D, Pulitzer M, Bini J, Arora R, Hanson NC, Tassello JA, Frosina D, Moore P, Chang Y.

Am J Surg Pathol. 2009 Sep;33(9):1378-85. doi: 10.1097/PAS.0b013e3181aa30a5.

27.

Expression of cancer-testis (CT) antigens in placenta.

Jungbluth AA, Silva WA Jr, Iversen K, Frosina D, Zaidi B, Coplan K, Eastlake-Wade SK, Castelli SB, Spagnoli GC, Old LJ, Vogel M.

Cancer Immun. 2007 Aug 24;7:15.

28.

NY-BR-1 is a differentiation antigen of the mammary gland.

Jäger D, Filonenko V, Gout I, Frosina D, Eastlake-Wade S, Castelli S, Varga Z, Moch H, Chen YT, Busam KJ, Seil I, Old LJ, Nissan A, Frei C, Gure AO, Knuth A, Jungbluth AA.

Appl Immunohistochem Mol Morphol. 2007 Mar;15(1):77-83.

PMID:
17536312
29.

Cancer/testis (CT) antigens are expressed in fetal ovary.

Nelson PT, Zhang PJ, Spagnoli GC, Tomaszewski JE, Pasha TL, Frosina D, Caballero OL, Simpson AJ, Old LJ, Jungbluth AA.

Cancer Immun. 2007 Jan 12;7:1.

30.

Clusterin expression in primary and metastatic melanoma.

Busam KJ, Kucukgol D, Eastlake-Wade S, Frosina D, Delgado R, Jungbluth AA.

J Cutan Pathol. 2006 Sep;33(9):619-23.

PMID:
16965336
31.

Glycoprotein A34, a novel target for antibody-based cancer immunotherapy.

Scanlan MJ, Ritter G, Yin BW, Williams C Jr, Cohen LS, Coplan KA, Fortunato SR, Frosina D, Lee SY, Murray AE, Chua R, Filonenko VV, Sato E, Old LJ, Jungbluth AA.

Cancer Immun. 2006 Jan 12;6:2.

32.

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen YT, Ohtani H, Old LJ, Odunsi K.

Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18538-43. Epub 2005 Dec 12.

33.

The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation.

Jungbluth AA, Ely S, DiLiberto M, Niesvizky R, Williamson B, Frosina D, Chen YT, Bhardwaj N, Chen-Kiang S, Old LJ, Cho HJ.

Blood. 2005 Jul 1;106(1):167-74. Epub 2005 Mar 10.

PMID:
15761016
34.

Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers.

Busam KJ, Kucukgöl D, Sato E, Frosina D, Teruya-Feldstein J, Jungbluth AA.

Am J Surg Pathol. 2005 Mar;29(3):400-6.

PMID:
15725810

Supplemental Content

Loading ...
Support Center